Potential calm before a storm, TBD. One thing's clear to me (for as little as that's worth), last year's heavy lean by many people on indexed portfolios may not navigate the waters as well as active management now and going forward. Or, I could be dead wrong on the latter.
www.nasdaq.com
Potential calm before a storm, TBD. One thing's clear to me (for as little as that's worth), last year's heavy lean by many people on indexed portfolios may not navigate the waters as well as active management now and going forward. Or, I could be dead wrong on the latter.
FEYE - Anyone else own FireEye (up 40% since purchase, BUT down 18% today) with a take on FEYE's announced plans 1. to sell their software/product and company name to Symphony Technology, 2. to focus instead on related cybersecurity consulting, servicing of FEYE and potentially other competing cybersecurity products, and 3. to repurchase about $500m of FEYE shares? Unclear on FEYE's management decision, yet separately added some CRWD on today's early dip ahead of AH 1Q results.
Here's Why FireEye Stock Plunged Today
What happened Shares of cybersecurity company FireEye (NASDAQ: FEYE) are plunging today after the company announced massive changes to its business. In short, it's selling some of its operations, buying back stock, and even changing its name to Mandiant. All of this change makes
Noted, albeit last year many dead, deaf, blind, and borderline comatose individual day traders and some LT investors with zero clue alike more than breakeven from April/May onward. Just IMHO, the times they have increasingly changed since the SARS-2 summer of 2020. Sure hope so on the health and vaccine front versus undesireable possible hybrid variant head fakes.
Additional preventative cybersecurity services make good sense, particularly regarding health care delivery, food, energy, necessary aviation and urban public transit, etc. Undoubtedly, public and private companies alike already employ sh|t loads of special forces tech veterans, hackers, and other wicked smaht techies. At least in one sector I've interacted with a fair amount, but clearly not adequately or in sufficient #s given recent examples (Colonial, JBS, etc). SmartWinds, yikes! As for FEYE, I'm going to Warde Manuel monitor it for a day or a few
Next week? Nyet, I went to town on Costco samples yesterday!
I have T1D. When the 365 day implantable sensor is approved (end of 2023) with the transmitter also subcutaneous it should really disrupt the market even with Dexcom most likely having rolled out by then the Dex G8 and G9. I wear the G7. The 180 is tempting but the 365 will be a MA$$IVE game changer.
Senseonics Announces Results of the PROMISE Study Demonstrating Strong Accuracy of 180 Day CGM Sensor
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system – the Eversense® CGM System – today announced the results of the PROMISE Study...au.finance.yahoo.com
Between this and AMC yesterday, been a good week.
renewpower.in
renewpower.in
When interest rates go up, we’ll see what happensPotential calm before a storm, TBD. One thing's clear to me (for as little as that's worth), last year's heavy lean by many people on indexed portfolios may not navigate the waters as well as active management now and going forward. Or, I could be dead wrong on the latter.
Could be, yet other earlier issues may potentially cause ripples sooner, e.g., Aside from global money center banks issuing sh|t loads of debt since Jan, prime brokers and retail-focused brokers very recently tightening margin requirements, limiting short sales, etc., how well have financial institutions mitigated or contained their own risks and institutional and retail client risks?
